Date: Thursday, March 20
Time: 3:00 – 4:00 p.m. (EDT)
This WuXi AppTec event is complementary and open to life science professionals globally.
For additional information and registration, please click here.
WHAT WILL BE COVERED
- Overview of 361/351 products, including regulations, development considerations, and challenges.
- Driving product quality through QbD comprising risk mitigation and testing strategies – from preclinical to commercial programs.
- New technologies for assessment of viral contaminants to donor cell lines and raw materials.
- Analysis of extractables/leachables for particulates and product purity, including product stability.
Alan Moore Vice President – Cell Manufacturing • Wuxi AppTec
Healther Malicki Director – Virology Technology Development • Wuxi AppTec
Sandi Schaible Director – Analytical Chemistry • Wuxi AppTec
Click here to register.
UPCOMING SPRING WEBINAR SERIES
APRIL | Translating Early-Stage Programs to Clinic-Ready Production – Including process scale-up considerations and applications of Corning HYPER® platform technologies
MAY | cGMP Compliance Trends and Challenges for Late-Stage Programs – Including timeline management, quality control, and rapid release of commercial-ready products
Sharmilee Patel • Business Development – Cell & Tissue Programs